Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

✍ Scribed by Alba A. Brandes; A. Tosoni; E. Franceschi; V. Blatt; A. Santoro; M. Faedi; P. Amistà; M. Gardiman; R. Labianca; C. Bianchini; M. Ermani; M. Reni

• Book ID: 105993077
• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 266 KB
• Volume: 64
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-009-0926-8